{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:31:50Z","timestamp":1793457110683,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade De S\u00e3o Paulo","id":[{"id":"https:\/\/ror.org\/036rp1748","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Hypophysitis in sarcoidosis is a rare manifestation of neurosarcoidosis that may cause permanent endocrine dysfunction, visual impairment, and neurological morbidity. We performed a systematic review to characterize its clinical presentation, diagnostic findings, treatment, and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Embase, and Scopus were searched from inception to January 22, 2025, for reports of adult patients with sarcoidosis-related hypophysitis. Cases were reassessed according to the 2018 Neurosarcoidosis Consortium Consensus Group criteria. Individual patient data were extracted regarding clinical manifestations, hormonal abnormalities, imaging findings, systemic involvement, treatment, recurrence, and long-term outcomes. Sensitivity analyses restricted the cohort to patients meeting definite or probable criteria and stratified cases by publication era (1954\u20131999, 2000\u20132017, 2018\u20132024) to assess the robustness of findings and the impact of temporal heterogeneity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 166 studies comprising 274 patients were included. Diagnostic certainty was definite in 26.3%, probable in 47.8%, and possible in 25.9% of cases. Median age was 37 years (IQR 28\u201348), and 53.5% were male. AVP deficiency was the most frequent manifestation (53.6%), followed by gonadal dysfunction (38.3%), visual loss (36.1%), headache (32.2%), and fatigue (30.5%). Central hypogonadism was the most common anterior pituitary abnormality (74.1%), followed by central hypothyroidism (63.6%) and hyperprolactinemia (58.1%). MRI most commonly demonstrated pituitary stalk thickening (43.1%) and sellar\/suprasellar masses (36.4%). CSF analysis frequently showed elevated protein (68.9%) and pleocytosis (59.5%). Systemic involvement occurred in 80.3% of patients, predominantly affecting lymph nodes and lungs. Although corticosteroids were the mainstay of treatment, recurrence occurred in 43.1% of patients, chronic hormone replacement was required in 36.2%, and long-term desmopressin dependence occurred in 30.5%. Findings were materially unchanged when restricted to the definite\/probable cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009203) and across publication eras, despite increased MRI use and greater adoption of steroid-sparing and biologic therapies over time.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hypophysitis in sarcoidosis should be suspected in patients presenting with stalk thickening, sellar lesions, AVP deficiency, or unexplained hypogonadism. Because serum and CSF biomarkers showed limited sensitivity, systemic investigation and extracranial biopsy are essential. Despite treatment, recurrence and persistent endocrine dysfunction remain common, highlighting the need for long-term multidisciplinary follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11102-026-01753-y","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:01:06Z","timestamp":1787230866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical presentation, investigation findings, and outcomes of hypophysitis in sarcoidosis: a systematic review"],"prefix":"10.1007","volume":"29","author":[{"given":"Julia F B","family":"Cavalcanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Caixeta","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Tavares","family":"Lucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Glezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Diogo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"4","key":"1753_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1136\/jnnp.2007.124263","volume":"7","author":"FG Joseph","year":"2007","unstructured":"Joseph FG, Scolding NJ (2007) Sarcoidosis of the nervous system. Pract Neurol 7(4):234\u2013244. https:\/\/doi.org\/10.1136\/jnnp.2007.124263 PubMed PMID: 17636138","journal-title":"Pract Neurol"},{"issue":"3","key":"1753_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/CON.0000000000000855","volume":"26","author":"S Pawate","year":"2020","unstructured":"Pawate S (2020) Sarcoidosis and the Nervous System. Continuum 26(3):695\u2013715 doi:10.1212\/CON.0000000000000855 PubMed PMID: 32487903","journal-title":"Continuum"},{"issue":"10","key":"1753_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","volume":"105","author":"C Langrand","year":"2012","unstructured":"Langrand C, Bihan H, Raverot G, Varron L, Androdias G, Borson-Chazot F et al (2012) Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients. QJM Mon J Assoc Physicians 105(10):981\u2013995. https:\/\/doi.org\/10.1093\/qjmed\/hcs121 PubMed PMID: 22753675","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"1","key":"1753_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12883-016-0741-x","volume":"16","author":"D Fritz","year":"2016","unstructured":"Fritz D, van de Beek D, Brouwer MC (2016) Clinical features, treatment, and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol 16(1):220. https:\/\/doi.org\/10.1186\/s12883-016-0741-x PubMed PMID: 27846819; PubMed Central PMCID: PMC5109654","journal-title":"BMC Neurol"},{"issue":"1","key":"1753_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.36141\/svdld.v36i1","volume":"36","author":"J Dorman","year":"2019","unstructured":"Dorman J, Warrior L, Pandya V, Sun Y, Ninan J, Trick W et al (2019) Neurosarcoidosis in a public safety net hospital: a study of 82 cases. Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG 36(1):25\u201332. https:\/\/doi.org\/10.36141\/svdld.v36i17106 PubMed PMID: 32476933; PubMed Central PMCID: PMC7247114","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis Off J WASOG"},{"key":"1753_CR6","doi-asserted-by":"publisher","first-page":"577871","DOI":"10.1016\/j.jneuroim.2022.577871","volume":"368","author":"P Barreras","year":"2022","unstructured":"Barreras P, Stern BJ (2022) Clinical features and diagnosis of neurosarcoidosis - review article. J Neuroimmunol 368:577871. https:\/\/doi.org\/10.1016\/j.jneuroim.2022.577871 PubMed PMID: 35523055","journal-title":"J Neuroimmunol"},{"key":"1753_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/B978-0-7020-4086-3","volume":"119","author":"A Krumholz","year":"2014","unstructured":"Krumholz A, Stern BJ (2014) Neurologic manifestations of sarcoidosis. Handb Clin Neurol 119:305\u2013333. https:\/\/doi.org\/10.1016\/B978-0-7020-4086-300021-7 PubMed PMID: 24365304","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"1753_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11102-015","volume":"19","author":"J Anthony","year":"2016","unstructured":"Anthony J, Esper GJ, Ioachimescu A (2016) Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review. Pituitary 19(1):19\u201329. https:\/\/doi.org\/10.1007\/s11102-015-0678-x PubMed PMID: 26267304","journal-title":"Pituitary"},{"issue":"5","key":"1753_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MD.0b013e31815585","volume":"86","author":"H Bihan","year":"2007","unstructured":"Bihan H, Christozova V, Dumas JL, Jomaa R, Valeyre D, Tazi A et al (2007) Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Med (Baltim) 86(5):259\u2013268. https:\/\/doi.org\/10.1097\/MD.0b013e31815585aa PubMed PMID: 17873755","journal-title":"Med (Baltim)"},{"issue":"6","key":"1753_CR10","doi-asserted-by":"publisher","first-page":"e1767","DOI":"10.1210\/clinem\/dgae","volume":"110","author":"L Miquel","year":"2025","unstructured":"Miquel L, Testud B, Albarel F, Sahakian N, Cuny T, Graillon T et al (2025) Deciphering the Presentation and Etiologies of Hypophysitis Highlights the Need for Repeated Systematic Investigation. J Clin Endocrinol Metab 110(6):e1767\u2013e1775. https:\/\/doi.org\/10.1210\/clinem\/dgae664 PubMed PMID: 39312231","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1753_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/qjmed\/hcg","volume":"96","author":"N Porter","year":"2003","unstructured":"Porter N, Beynon HL, Randeva HS (2003) Endocrine and reproductive manifestations of sarcoidosis. QJM Mon J Assoc Physicians 96(8):553\u2013561. https:\/\/doi.org\/10.1093\/qjmed\/hcg103 PubMed PMID: 12897340","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"12","key":"1753_CR12","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","volume":"75","author":"BJ Stern","year":"2018","unstructured":"Stern BJ, Royal W, Gelfand JM, Clifford DB, Tavee J, Pawate S et al (2018) Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group. JAMA Neurol 75(12):1546\u20131553. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2295 PubMed PMID: 30167654","journal-title":"JAMA Neurol"},{"issue":"19","key":"1753_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJM198011063031902","volume":"303","author":"CA Stuart","year":"1980","unstructured":"Stuart CA, Neelon FA, Lebovitz HE (1980) Disordered Control of Thirst in Hypothalamic-Pituitary Sarcoidosis. N Engl J Med 303(19):1078\u20131082. https:\/\/doi.org\/10.1056\/NEJM198011063031902","journal-title":"N Engl J Med"},{"issue":"7","key":"1753_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/BF03345093","volume":"25","author":"G Murialdo","year":"2002","unstructured":"Murialdo G, Tamagno G (2002) Endocrine aspects of neurosarcoidosis. J Endocrinol Invest 25(7):650\u2013662 doi:10.1007\/BF03345093 PubMed PMID: 12150344","journal-title":"J Endocrinol Invest"},{"key":"1753_CR15","doi-asserted-by":"publisher","unstructured":"Akaike G, Itani M, Shah H, Ahuja J, Gunes BY, Assaker R, Behnia F (2018) PET\/CT in the Diagnosis and Workup of Sarcoidosis: focus on atypical manifestations. Radiographics 38(5):1536\u20131549. https:\/\/doi.org\/10.1148\/rg.2018180053","DOI":"10.1148\/rg.2018180053"},{"issue":"2","key":"1753_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/acn3.51968","volume":"11","author":"S Chaiyanarm","year":"2024","unstructured":"Chaiyanarm S, Satiraphan P, Apiraksattaykul N, Jitprapaikulsan J, Owattanapanich W, Rungjirajittranon T et al (2024) Infliximab in neurosarcoidosis: a systematic review and meta-analysis. Ann Clin Transl Neurol 11(2):466\u2013476. https:\/\/doi.org\/10.1002\/acn3.51968","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"1753_CR17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1183\/09031936.00051907","volume":"31","author":"MA Judson","year":"2008","unstructured":"Judson MA, Baughman RP, Costabel U, Flavin S, Lo KH, Kavuru MS et al (2008) Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 31(6):1189\u20131196. https:\/\/doi.org\/10.1183\/09031936.00051907 PubMed PMID: 18256069","journal-title":"Eur Respir J"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01753-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01753-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01753-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T14:11:52Z","timestamp":1793455912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01753-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01753-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Not applicable","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"Not applicable","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"148"}}